ACADIA Pharmaceuticals Inc. (ACAD) announced after the bell Tuesday that it intends to offer and sell shares of its common stock in an underwritten public offering. The stock is now down 0.62 on 46K shares.
ACADIA Pharmaceuticals traded in a range throughout Tuesday's session and closed up by 0.25 at $12.95. The stock finished near the middle of a 1-month range at the highs of the year.
For comments and feedback: editorial@rttnews.com